Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

Systematic review of migraine prophylaxis adherence and persistence.

Hepp Z, Bloudek LM, Varon SF.

J Manag Care Pharm. 2014 Jan;20(1):22-33. Review.

2.

Persistence with migraine prophylactic treatment and acute migraine medication utilization in the managed care setting.

Yaldo AZ, Wertz DA, Rupnow MF, Quimbo RM.

Clin Ther. 2008 Dec;30(12):2452-60. doi: 10.1016/j.clinthera.2008.12.010.

PMID:
19167603
3.

Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.

Iglay K, Cartier SE, Rosen VM, Zarotsky V, Rajpathak SN, Radican L, Tunceli K.

Curr Med Res Opin. 2015;31(7):1283-96. doi: 10.1185/03007995.2015.1053048. Epub 2015 Jun 18.

PMID:
26023805
4.

Drugs for preventing migraine headaches in children.

Victor S, Ryan SW.

Cochrane Database Syst Rev. 2003;(4):CD002761. Review. Update in: Cochrane Database Syst Rev. 2014;7:CD002761.

PMID:
14583952
5.

Topiramate for migraine prophylaxis in pediatric patients.

Deaton TL, Mauro LS.

Ann Pharmacother. 2014 May;48(5):638-43. doi: 10.1177/1060028014521128. Epub 2014 Feb 24. Review.

PMID:
24566461
6.

Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.

Seeburger JL, Cady RK, Winner P, MacGregor A, Valade D, Ge Y, Zhang Y, Hustad CM, Strickler N, Schaefer E, Connor KM, Ho TW.

Headache. 2012 Jan;52(1):57-67. doi: 10.1111/j.1526-4610.2011.02027.x. Epub 2011 Nov 11.

PMID:
22078129
7.

Pediatric migraine: pharmacologic agents for prophylaxis.

Eiland LS, Jenkins LS, Durham SH.

Ann Pharmacother. 2007 Jul;41(7):1181-90. Epub 2007 Jun 5. Review.

PMID:
17550953
8.

Topiramate in patients with episodic migraine: reducing the risk for chronic forms of headache.

Limmroth V, Biondi D, Pfeil J, Schwalen S.

Headache. 2007 Jan;47(1):13-21.

PMID:
17355489
9.

Health care resource utilization following initiation of a triptan: a retrospective claims analysis.

Messali A, Owens G, Bloudek L, Kori S, Cole A, Chia J.

J Manag Care Spec Pharm. 2014 Apr;20(4):368-75.

10.

Cost-minimization analysis comparing topiramate with standard treatments in migraine prophylaxis.

Ergun H, Gulmez SE, Tulunay FC.

Eur Neurol. 2007;58(4):215-7. Epub 2007 Sep 7.

PMID:
17827966
11.

Adherence to oral migraine-preventive medications among patients with chronic migraine.

Hepp Z, Dodick DW, Varon SF, Gillard P, Hansen RN, Devine EB.

Cephalalgia. 2015 May;35(6):478-88. doi: 10.1177/0333102414547138. Epub 2014 Aug 27.

PMID:
25164920
12.

Topiramate in migraine prevention: evidence-based medicine from clinical trials.

Silberstein SD.

Neurol Sci. 2004 Oct;25 Suppl 3:S244-5.

PMID:
15549548
13.

Topiramate in migraine prophylaxis: data from a pooled analysis and open-label extension study.

Bussone G, Usai S, D'Amico D.

Neurol Sci. 2006 May;27 Suppl 2:S159-63. Review.

PMID:
16688622
14.

Tonabersat for migraine prophylaxis: a systematic review.

Cao Y, Zheng OJ.

Pain Physician. 2014 Jan-Feb;17(1):1-8. Review.

15.

Assessing clinically meaningful treatment effects in controlled trials: chronic migraine as an example.

Dodick DW, Turkel CC, DeGryse RE, Diener HC, Lipton RB, Aurora SK, Nolan ME, Silberstein SD.

J Pain. 2015 Feb;16(2):164-75. doi: 10.1016/j.jpain.2014.11.004. Epub 2014 Nov 15.

PMID:
25464159
16.

Topiramate in the prevention of pediatric migraine: literature review.

Ferraro D, Di Trapani G.

J Headache Pain. 2008 Jun;9(3):147-50. doi: 10.1007/s10194-008-0030-1. Epub 2008 Apr 2. Review.

17.

General lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic review.

Hougaard A, Tfelt-Hansen P.

Cephalalgia. 2016 Sep;36(10):960-9. doi: 10.1177/0333102415616880. Epub 2015 Nov 8. Review.

PMID:
26553731
18.

Topiramate 100 mg/day in migraine prevention: a pooled analysis of double-blind randomised controlled trials.

Bussone G, Diener HC, Pfeil J, Schwalen S.

Int J Clin Pract. 2005 Aug;59(8):961-8.

PMID:
16033621
19.

Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial.

Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J; Topiramate Pediatric Migraine Study Investigators.

Headache. 2005 Nov-Dec;45(10):1304-12.

PMID:
16324162
20.

Treatment persistence and switching in triptan users: a systematic literature review.

Messali AJ, Yang M, Gillard P, Tsai K, Tepper SJ, Bloudek LM, Kori SH.

Headache. 2014 Jul-Aug;54(7):1120-30. doi: 10.1111/head.12404. Epub 2014 Jun 10. Review.

PMID:
24912394

Supplemental Content

Support Center